Fundraising Fox
Syntr Health Technologies
Irvine, US · Founded 2018 · Delaware corporation
Find your way into Syntr Health Technologies
Sign up to see every warm intro you have to Syntr Health Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Syntr Health Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing. The device is aimed at clinical practices—including plastic, orthopedic, wound care, gastrointestinal, and veterinary surgeons—enabling in-office fat transfer procedures.
Founders & leadership
Funding
SEC filings, press & company announcements$5.1M disclosed across 3 rounds · 2018–2022
- $2.2MSeed RoundAug 2021 · 2 sourcesSource ↗
▶$795KraisedSep 2022 · 6 investors · BiotechnologyRule 506(b)
- Hugo SalasDirector
- Dane ShacklefordDirector
- Ahmed ZobiExecutive Officer, Director
- Amount sold
- $795K
- Minimum investment
- $5K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.2MraisedJul 2021 · 23 investors · BiotechnologyRule 506(b)
- Ahmed ZobiExecutive Officer, Director
- Hugo SalasDirector
- Dane ShacklefordDirector
- Amount sold
- $2.2M
- Minimum investment
- $5K
- Sales commissions
- $8K
- Placement agents
- HUBBLE INVESTMENTS, LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Syntr Health Technologies do?
- Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing. The device is aimed at clinical practices—including plastic, orthopedic, wound care, gastrointestinal, and veterinary surgeons—enabling in-office fat transfer procedures.
- How much funding has Syntr Health Technologies raised?
- Syntr Health Technologies has disclosed $5.1M raised across 3 rounds.
- Where is Syntr Health Technologies headquartered?
- Syntr Health Technologies is headquartered in Irvine, US.